[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US3050532A - Two stage oxidation of sclareol - Google Patents

Two stage oxidation of sclareol Download PDF

Info

Publication number
US3050532A
US3050532A US821345A US82134559A US3050532A US 3050532 A US3050532 A US 3050532A US 821345 A US821345 A US 821345A US 82134559 A US82134559 A US 82134559A US 3050532 A US3050532 A US 3050532A
Authority
US
United States
Prior art keywords
sclareol
compound
oxidation
oxidizing
permanganate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US821345A
Inventor
Joseph N Schumacher
Henley Walter Maurey
Jr Claude E Teague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RJ Reynolds Tobacco Co
Original Assignee
RJ Reynolds Tobacco Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RJ Reynolds Tobacco Co filed Critical RJ Reynolds Tobacco Co
Priority to US821345A priority Critical patent/US3050532A/en
Application granted granted Critical
Publication of US3050532A publication Critical patent/US3050532A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0069Heterocyclic compounds
    • C11B9/0073Heterocyclic compounds containing only O or S as heteroatoms
    • C11B9/0076Heterocyclic compounds containing only O or S as heteroatoms the hetero rings containing less than six atoms

Definitions

  • This invention relates to oxidation and has for an object the provision of a process for oxidizing sclareol to form decahydro 3a,6,6,9a tetramethylnaphtho[2,143]- turan-2( 1H) -one.
  • the terpene-like compound sclareol is known to be a component of clary sage (Salvia sclarea) and it may be obtained from clary sage by extraction of the flowering parts of the plant with a suitable solvent such as hexane. It is also known, as set forth in the copending application of Joseph N. Schumacher, Serial No. 708,987, filed January 15, 1958, now Patent No. 2,905,576, issued September 22, 1958, that sclareol may be converted to decahydro-3a,6,6,9a-tetramethylnaphtho[2,1b] furan 2(1H) one (compound I) which has the following structural formula:
  • This compound I as disclosed in said Schumacher application has been found to be particularly useful for incorporation into domestic tobaccos in order to increase the odor and flavor of the tobacco smoke.
  • an object of this invention is the provision of a process for oxidizing sclareol to produce compound 1 whereby high yields of compound I are obtainable.
  • a further object of this invention is the provision of a process for producing compound I from sclareol which is simple and safe to carry out in a commercial scale operation.
  • a still further object of this invention is the provision of a sclareol oxidation process carried out under conditions whereby the major proportion of the sclareol is oxidized to produce compound I and only small amounts of undesired reaction products are produced.
  • compound I is produced from sclareol in high yields when the oxidation is carried out in two separate steps.
  • the sclareol is partially oxidized with an alkali metal permanganate under alkaline conditions and then the oxidation of the reaction mixture is completed in a second step under acid conditions.
  • an alkali metal permanganate or chromic acid may be used as the oxidizing agent.
  • the molar ratio of sclareol to permanganate in the first step of the oxidation should be between about 1 to 2 and about 1 to 5 and then in the second step the balance of the oxidizing agent is employed so that the total amount of oxidizing agent used in both steps corresponds to between about 6 to 8 moles of the oxidizing agent per mole of sclareol.
  • Example I To 205.6 g. (0.67 mole) of sclareol and 1435 ml, of Water in a jacketed reaction vessel is added 379.5 g. of 2.4 moles) of KMnO4 over three hours. The reaction mixture is agitated vigorously during the addition. The reaction temperature is maintained between 30 and 35 C. and the reaction medium is alkaline during this stage of the oxidation due to the KOH liberated in the reaction. Agitation is continued for an additional two hours and the first step of the reaction is completed.
  • a liter of water is then added and the mixture is acidified to pH 2 with H Normally, one liter of 7 .N H 504 is required.
  • the mixture is cooled to 10 C. and S0 is added to convert the precipitated MnO to the water soluble MnSO The S0 is added over a 70 minute period and at a temperature below 15 C.
  • the solid product dispersed in the aqueous medium at this stage comprises a mixture of compound I and a substantial amount of an acetoxy acid (2-acetoxy-2,5,5,8atetramethyldecahydro naphthalene acetic acid) having the structure:
  • the organic mixture is separated from the aqueous phase by filtration and is dried in the air to constant weight.
  • the dried product is then hydrolyzed or saponified under reflux over 3 hours in a solution consisting of g. of KOH, ml. of water, and 1500 ml. of methanol.
  • the methanol is removed by distillation at reduced pressure.
  • the residue from the distillation is dissolved in 2 liters of water and the solution is washed with 2500 ml. of hexane.
  • the washed aqueous layer is then acidified with 6 N H 50 to a pH of 2.
  • the hydroxy acid (2-hydroxy- 2,5,5,8a-tetrarnethyldecahydro naphthalene acetic acid) which precipitates has the formula and is isolated by filtration.
  • the solid is dried in the air and is then heated at 135-145 C. for 1.5 to 2 hours to convert it to the desired lactone product (compound I).
  • the lactone is purified by crystallization from hexane.
  • the yield of pure product by this process has averaged 108 g; yield, basis starting sclareol, 65%; melting point, 123124 C.
  • Example 11 In this example the process is essentially the same as disclosed in Example I except that an equivalent amount of chromic acid is substituted for the permanganate employed in the acid oxidizing step. Essentially the same yields of compound I are obtained.
  • the process is carried out in two oxidation steps but it is not required to subject the product from the first step to any purification and the entire reaction mixture from the first step is treated directly in the second oxidizing step.
  • the alkali metal permanganate in the first step and when used in the second step may be either sodium or potassium permanganate, but other salts of permanganic acid may be used, such as calcium, magnesium or other salt-forming cations.
  • the temperatures employed in the first step may be between about 0 and 50 C., preferably about 30 to 40 C., and in the second step may be between about 0 and 20 C., preferably about 0 to 10 C.
  • acetic or propionic acid may be used to provide the acid conditions; however, any suitable nonoxidizing acid may be used.
  • a process of preparing the compound decahydro- 3a,6,6,9-a-tetramethylnaphtho[2,l-b1furan 2(lH) one which comprises the first step of intimately contacting an aqueous dispersion of sclareol with an alkali metal permanganate oxidizing agent under alkaline oxidizing conditions to partially oxidize the sclareol, the second step of acidifying the resulting aqueous reaction mixtures and intimately contacting it with an oxidizing agent selected from the group consisting of a permanganate and chromic acid under acid oxidizing conditions whereby the oxidation is completed, separating a solid mixture of said compound and an intermediate 2-acetoxy-2,5,5,8a-tetramethyldecahydronaphthalene acetic acid from the reaction medium and thereafter subjecting the last mentioned mixture successively to saponification, acidifying and dehydrating conditions whereby to form said compound.
  • a process of preparing" the compound decahydro- 321,6,6,9a-tetramethylnaphtho[2,l-b]furan 2(lH) one which comprises the first step of intimately contacting an aqueous dispersion of sclareol with an alkali metal permanganate oxidizing agent under alkaline oxidizing conditions at a temperature between about 0 and about 50 C. to partially oxidize the sclareol, the second step of acidifying the resulting aqueous reaction mixture and intimately contacting it with an oxidizing agent selected from the group consisting of a permanganate and chromic acid under acid oxidizing conditions at a temperature between about 0 and about 20 C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

United States Patent 3,050,532 TWO STAGE OXIDATION OF SCLAREOL Joseph N. Schumacher, Walter Maurey Henley, Edward Bemasek, and Claude E. Teague, In, all of Winston- Salem, N.C., assignors to R. J. Reynolds Tobacco Company, Winston-Salem, N.C., a corporation of New Jersey No Drawing. Filed June 19, 1959, Ser. No. 821,345
7 Claims. (Cl. 260-3433) This invention relates to oxidation and has for an object the provision of a process for oxidizing sclareol to form decahydro 3a,6,6,9a tetramethylnaphtho[2,143]- turan-2( 1H) -one.
As well known in the art, the terpene-like compound sclareol is known to be a component of clary sage (Salvia sclarea) and it may be obtained from clary sage by extraction of the flowering parts of the plant with a suitable solvent such as hexane. It is also known, as set forth in the copending application of Joseph N. Schumacher, Serial No. 708,987, filed January 15, 1958, now Patent No. 2,905,576, issued September 22, 1959, that sclareol may be converted to decahydro-3a,6,6,9a-tetramethylnaphtho[2,1b] furan 2(1H) one (compound I) which has the following structural formula:
CH3 CH3 CH3 GHQ-0:0
This compound I as disclosed in said Schumacher application has been found to be particularly useful for incorporation into domestic tobaccos in order to increase the odor and flavor of the tobacco smoke.
Accordingly, an object of this invention is the provision of a process for oxidizing sclareol to produce compound 1 whereby high yields of compound I are obtainable.
A further object of this invention is the provision of a process for producing compound I from sclareol which is simple and safe to carry out in a commercial scale operation.
A still further object of this invention is the provision of a sclareol oxidation process carried out under conditions whereby the major proportion of the sclareol is oxidized to produce compound I and only small amounts of undesired reaction products are produced.
Further and additional objects will appear from the following description and the accompanying claims.
Thus in accordance with one embodiment of this invention, compound I is produced from sclareol in high yields when the oxidation is carried out in two separate steps. In the first step the sclareol is partially oxidized with an alkali metal permanganate under alkaline conditions and then the oxidation of the reaction mixture is completed in a second step under acid conditions. In the second step either an alkali metal permanganate or chromic acid may be used as the oxidizing agent. Furthermore, it has been found that about six moles of permanganate or chromic acid are theoretically required to oxidize sclareol whereby to produce the desired compound I. Usually some excess of the oxidizing agent is employed. Thus it is preferred in accordance with one embodiment of this invention that the molar ratio of sclareol to permanganate in the first step of the oxidation should be between about 1 to 2 and about 1 to 5 and then in the second step the balance of the oxidizing agent is employed so that the total amount of oxidizing agent used in both steps corresponds to between about 6 to 8 moles of the oxidizing agent per mole of sclareol.
Sclareol and its related oxidation products are insoluble in water and perhaps for this reason organic solvents have been employed in carrying out reactions of this general type. However, the alkali metal salts, such as the potassium salts, of certain acidic intermediate oxidation products are water soluble and in accordance with this invention it has been discovered that water may be very elfectively used as the menstruum for carrying out both steps (and particularly the first step) of the oxidation. By utilizing water many operating hazards are avoided which are known to be incident to carrying out oxidation procedures in the presence of organic solvents, such as acetone, alcohols, ether or the like.
For a more complete understanding of this invention, reference will now be made to examples for preparing compound I by the two step oxidation of sclareol.
Example I To 205.6 g. (0.67 mole) of sclareol and 1435 ml, of Water in a jacketed reaction vessel is added 379.5 g. of 2.4 moles) of KMnO4 over three hours. The reaction mixture is agitated vigorously during the addition. The reaction temperature is maintained between 30 and 35 C. and the reaction medium is alkaline during this stage of the oxidation due to the KOH liberated in the reaction. Agitation is continued for an additional two hours and the first step of the reaction is completed.
To the partially oxidized reaction mixture is added 1435 ml. of glacial acetic acid. With vigorous agitation, an adidtional 254 g. (1.6 moles) of KMnO is added together with 104 ml. of glacial acetic acid over a two-hour period. The temperature is maintained over the range 8l0 C. Stirring is continued for an additional 20 to 30 minutes at the same temperature. The mixture is then allowed to stand at room temperature for 15 hours. Stirring is resumed and continued for two hours at room temperature. At this stage the second oxidation step is completed.
A liter of water is then added and the mixture is acidified to pH 2 with H Normally, one liter of 7 .N H 504 is required. The mixture is cooled to 10 C. and S0 is added to convert the precipitated MnO to the water soluble MnSO The S0 is added over a 70 minute period and at a temperature below 15 C.
The solid product dispersed in the aqueous medium at this stage comprises a mixture of compound I and a substantial amount of an acetoxy acid (2-acetoxy-2,5,5,8atetramethyldecahydro naphthalene acetic acid) having the structure:
CH! -OC OCH;
CH; CHQOOEH The organic mixture is separated from the aqueous phase by filtration and is dried in the air to constant weight. The dried product is then hydrolyzed or saponified under reflux over 3 hours in a solution consisting of g. of KOH, ml. of water, and 1500 ml. of methanol. The methanol is removed by distillation at reduced pressure. The residue from the distillation is dissolved in 2 liters of water and the solution is washed with 2500 ml. of hexane. The washed aqueous layer is then acidified with 6 N H 50 to a pH of 2. The hydroxy acid (2-hydroxy- 2,5,5,8a-tetrarnethyldecahydro naphthalene acetic acid) which precipitates has the formula and is isolated by filtration. The solid is dried in the air and is then heated at 135-145 C. for 1.5 to 2 hours to convert it to the desired lactone product (compound I). The lactone is purified by crystallization from hexane. The yield of pure product by this process has averaged 108 g; yield, basis starting sclareol, 65%; melting point, 123124 C.
Example 11 In this example the process is essentially the same as disclosed in Example I except that an equivalent amount of chromic acid is substituted for the permanganate employed in the acid oxidizing step. Essentially the same yields of compound I are obtained.
Thus it will be apparent that a simple process has been devised for preparing high yields of compound I from sclareol. The process is carried out in two oxidation steps but it is not required to subject the product from the first step to any purification and the entire reaction mixture from the first step is treated directly in the second oxidizing step. The alkali metal permanganate in the first step and when used in the second step may be either sodium or potassium permanganate, but other salts of permanganic acid may be used, such as calcium, magnesium or other salt-forming cations. The temperatures employed in the first step may be between about 0 and 50 C., preferably about 30 to 40 C., and in the second step may be between about 0 and 20 C., preferably about 0 to 10 C. In the second step acetic or propionic acid may be used to provide the acid conditions; however, any suitable nonoxidizing acid may be used.
While particular embodiments of this invention are shown above, it will be understood, of course, that the invention is not to be limited thereto, since many modifications may be made, and it is contemplated, therefore, by the appended claims, to cover any such modifications as fall within the true spirit and scope of this invention.
We claim:
1. A process of preparing the compound decahydro- 3a,6,6,9-a-tetramethylnaphtho[2,l-b1furan 2(lH) one which comprises the first step of intimately contacting an aqueous dispersion of sclareol with an alkali metal permanganate oxidizing agent under alkaline oxidizing conditions to partially oxidize the sclareol, the second step of acidifying the resulting aqueous reaction mixtures and intimately contacting it with an oxidizing agent selected from the group consisting of a permanganate and chromic acid under acid oxidizing conditions whereby the oxidation is completed, separating a solid mixture of said compound and an intermediate 2-acetoxy-2,5,5,8a-tetramethyldecahydronaphthalene acetic acid from the reaction medium and thereafter subjecting the last mentioned mixture successively to saponification, acidifying and dehydrating conditions whereby to form said compound.
2. The process recited in claim 1 in which chromic acid is the oxidizing agent used in the second step.
3. The process recited in claim 1 in which a permanganate is the oxidizing agent used in the second step.
4. A process of preparing" the compound decahydro- 321,6,6,9a-tetramethylnaphtho[2,l-b]furan 2(lH) one which comprises the first step of intimately contacting an aqueous dispersion of sclareol with an alkali metal permanganate oxidizing agent under alkaline oxidizing conditions at a temperature between about 0 and about 50 C. to partially oxidize the sclareol, the second step of acidifying the resulting aqueous reaction mixture and intimately contacting it with an oxidizing agent selected from the group consisting of a permanganate and chromic acid under acid oxidizing conditions at a temperature between about 0 and about 20 C. whereby the oxidation is completed, separating a solid mixture of said compound and an intermediate 2-acetoxy-2,5,5,8a-tetrarnethyldecahydronaphtha'lene acetic acid from the reaction medium and thereafter subjecting the last mentioned mixture successively to saponificaion, acidifying and dehydrating conditions whereby to form said compound.
5. The process recited in claim 4 wherein the molar ratio of sclareol to permanganate in said first step is between about 1 to 2 and about 1 to 5 and the total molar ratio of sclareol to the total amount of oxidizing agents employed in both said first and second steps being between about 1 to 6 and about 1 to 8.
6. The process of preparing the compound decahydro- 3a,6,6,9a-tetrarnethylnaphtho[2,1-b1furan 2(lH) one which comprises the first step of intimately contacting an aqueous dispersion of sclareol with an alkali metal permanganate oxidizing agent under alkaline oxidizing conditions to partially oxidize the sclareol, the second step of acidifying the resulting aqueous medium and intimately contacting it with an oxidizing agent selected from the group consisting of a permanganate and chromic acid under acid oxidizing conditions whereby the oxidation is completed, further acidifying the resulting aqueous reaction mixture if necessary whereby a solid comprising 'rnanganese dioxide, said compound and an intermediate 2-acetoxy-2,5,5,8a-tetramethyldecahydronaphthalene acetic acid is dispersed in the mixture, treating the aqueous mixture with sulfur dioxide to convert the manganese dioxide to the water soluble salts of manganese, separating the remainder of said solid from the sulfur dioxidetreated mixture, and subjecting the separated substances successively to saponification, acidifying and dehydrating conditions whereby to form said compound.
7. The process recited in claim 6 wherein the first oxidizing step is carried out at a temperature between about 0 and about 50 C. and wherein the second oxidizing step is carried out at a temperature between about 0 and about 20 C.
References Cited in the file of this patent UNITED STATES PATENTS Stoll Oct. 15, 1957 Ohlofi Nov. 24, 1959 OTHER REFERENCES

Claims (1)

1. A PROCESS OF PREPARING THE COMPOUND DECAHYDRO3A,6,6,9A-TETRAMETHYLNAPHTHO(2,1-B) FURAN-2 (IH) -ONE WHICH COMPRISES THE FIRST STEP OF INTIMATELY CONTACTING AN AQUEOUS DISPERSION OF SCLAREOL WITH AN ALKALI METAL PERMANGANATE OXIDIZING AGENT UNDER ALKALINE OXIDIZING CONDITIONS TO PARTIALLY OXIDIZE THE SCLAREOL, THE SECOND STEP OF ACIDIFYING THE RESULTING AQUEOUS REACTION MIXTURES AND INTIMATELY CONTRACTING IT WITH AN OXIDIZING AGENT SELECTED FROM THE GROUP CONSISTING OF A PERMANGANATE AND CHROMIC ACID UNDER ACID OXIDIZING CONDITIONS WHEREBY THE OXIDATION IS COMPLETED, SEPARATING A SOLID MIXTURE OF SAID COMPOUND AND AN INTERMEDIATE 2-ACETOXY-2,5,8A-TETRAMETHYLDECAHYDRONAPHTHALENE ACETIC ACID FROM THE REACTION MEDIUM AND THEREAFTER SUBJECTING THE LAST MENTIONED MIXTURE SUCESSIVELY TO SAPONIFICATION, ACIDIFYING AND DEHYDRATING CONDITIONS WHEREBY TO FORM SAID COMPOUND.
US821345A 1959-06-19 1959-06-19 Two stage oxidation of sclareol Expired - Lifetime US3050532A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US821345A US3050532A (en) 1959-06-19 1959-06-19 Two stage oxidation of sclareol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US821345A US3050532A (en) 1959-06-19 1959-06-19 Two stage oxidation of sclareol

Publications (1)

Publication Number Publication Date
US3050532A true US3050532A (en) 1962-08-21

Family

ID=25233128

Family Applications (1)

Application Number Title Priority Date Filing Date
US821345A Expired - Lifetime US3050532A (en) 1959-06-19 1959-06-19 Two stage oxidation of sclareol

Country Status (1)

Country Link
US (1) US3050532A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3203857A (en) * 1963-01-18 1965-08-31 Ciba Geigy Corp Analgesic compositions comprising a lactone obtained from helenium
US3203953A (en) * 1963-01-18 1965-08-31 Ciba Geigy Corp Lactone obtained from helenium sp. and derivatives thereof
WO1991009852A1 (en) * 1989-12-21 1991-07-11 Henkel Kommanditgesellschaft Auf Aktien Process for producing sclareolide
US5151411A (en) * 1990-08-24 1992-09-29 Givaudan Corporation Tricyclic ketones and fragrance compositions containing same
DE4123767A1 (en) * 1991-07-18 1993-01-21 Henkel Kgaa PROCESS FOR PREPARING 8,12-OXIDO-13,14,15,16-TETRANORLABDANE
EP0550889A1 (en) * 1991-12-29 1993-07-14 Kuraray Co., Ltd. Process for producing L-Ambrox
WO1993021174A1 (en) * 1992-04-16 1993-10-28 Henkel Kommanditgesellschaft Auf Aktien Process for producing sclareolide
US5434300A (en) * 1987-06-23 1995-07-18 Christenson; Philip A. Method for preparing dodecahydro-3A,6,6,9A-tetramethylnaphtho [2,1-B]furan and novel haloethyl decalin derivatives
US5670670A (en) * 1993-12-03 1997-09-23 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8 α, 12-oxido-13,14,15,16-tetranorlabdane
US5688976A (en) * 1993-12-03 1997-11-18 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8 α, 12-oxido-13,14,15,16-tetranorlabdane
EP0822191A1 (en) * 1996-08-02 1998-02-04 Quest International B.V. Preparation of intermediates for norlabdane oxide
US5811560A (en) * 1994-11-05 1998-09-22 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8α, 12-oxido-13, 14,15,16-tetranorlabdane
US5821375A (en) * 1996-08-02 1998-10-13 Quest International B.V. Preparation of norlabdane oxide
WO2009010791A2 (en) * 2007-07-13 2009-01-22 Imperial Chemical Industries Plc Cyclic ethers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809996A (en) * 1950-10-24 1957-10-15 Firmenich & Co Compounds having an ambergris scent and their preparation
US2914565A (en) * 1954-07-16 1959-11-24 Dragoco Gerberding Co Gmbh Products having ambergris aroma and a process of making same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809996A (en) * 1950-10-24 1957-10-15 Firmenich & Co Compounds having an ambergris scent and their preparation
US2914565A (en) * 1954-07-16 1959-11-24 Dragoco Gerberding Co Gmbh Products having ambergris aroma and a process of making same

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3203857A (en) * 1963-01-18 1965-08-31 Ciba Geigy Corp Analgesic compositions comprising a lactone obtained from helenium
US3203953A (en) * 1963-01-18 1965-08-31 Ciba Geigy Corp Lactone obtained from helenium sp. and derivatives thereof
US5571939A (en) * 1987-06-23 1996-11-05 Basf Corporation Method for preparing dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b]furan and novel haloethyl decalin derivatives
US5434300A (en) * 1987-06-23 1995-07-18 Christenson; Philip A. Method for preparing dodecahydro-3A,6,6,9A-tetramethylnaphtho [2,1-B]furan and novel haloethyl decalin derivatives
US5247100A (en) * 1989-12-21 1993-09-21 Henkel Kommanditgesellschaft Auf Aktien Process for the production of sclareolide
WO1991009852A1 (en) * 1989-12-21 1991-07-11 Henkel Kommanditgesellschaft Auf Aktien Process for producing sclareolide
US5151411A (en) * 1990-08-24 1992-09-29 Givaudan Corporation Tricyclic ketones and fragrance compositions containing same
DE4123767A1 (en) * 1991-07-18 1993-01-21 Henkel Kgaa PROCESS FOR PREPARING 8,12-OXIDO-13,14,15,16-TETRANORLABDANE
US5470989A (en) * 1991-07-18 1995-11-28 Henkel Kommanditgesellschaft Auf Aktien Process for the production of mixtures of stereoisomers of 8,12-oxido-13,14,15,16-tetranorlabdane
EP0550889A1 (en) * 1991-12-29 1993-07-14 Kuraray Co., Ltd. Process for producing L-Ambrox
US5290955A (en) * 1991-12-29 1994-03-01 Kuraray Co., Ltd. Process for producing L-ambrox
WO1993021174A1 (en) * 1992-04-16 1993-10-28 Henkel Kommanditgesellschaft Auf Aktien Process for producing sclareolide
US5525728A (en) * 1992-04-16 1996-06-11 Henkel Kommanditgesellschaft Auf Aktien Process for the production of sclareolide
US5670670A (en) * 1993-12-03 1997-09-23 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8 α, 12-oxido-13,14,15,16-tetranorlabdane
US5688976A (en) * 1993-12-03 1997-11-18 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8 α, 12-oxido-13,14,15,16-tetranorlabdane
US5811560A (en) * 1994-11-05 1998-09-22 Henkel Kommanditgesellschaft Auf Aktien Process for the production of 8α, 12-oxido-13, 14,15,16-tetranorlabdane
EP0822191A1 (en) * 1996-08-02 1998-02-04 Quest International B.V. Preparation of intermediates for norlabdane oxide
US5821375A (en) * 1996-08-02 1998-10-13 Quest International B.V. Preparation of norlabdane oxide
WO2009010791A2 (en) * 2007-07-13 2009-01-22 Imperial Chemical Industries Plc Cyclic ethers
US20100274030A1 (en) * 2007-07-13 2010-10-28 Hanamanthsa Shankarsa Bevinakatti Cyclic ethers
JP2011501729A (en) * 2007-07-13 2011-01-13 インペリアル ケミカル インダストリーズ ピーエルシー Cyclic ether
WO2009010791A3 (en) * 2007-07-13 2011-06-09 Imperial Chemical Industries Plc Cyclic ethers
US8536349B2 (en) 2007-07-13 2013-09-17 Givaudan S.A. Cyclic ethers
CN102015702B (en) * 2007-07-13 2013-12-25 吉沃丹S.A.公司 Cyclic ethers

Similar Documents

Publication Publication Date Title
US3050532A (en) Two stage oxidation of sclareol
Stille et al. Oxirene. An intermediate in the peroxyacid oxidation of acetylenes
Arnold et al. Photochemical reactions. Part II. Cycloaddition reactions with photoenols from 2-methylbenzaldehyde and related systems
US5247100A (en) Process for the production of sclareolide
SU727139A3 (en) Method of preparing optically active 11-desoxy-16-aryl-omega-tetranorprostaglandines or their racemates or their salts
US2750405A (en) Hydroxydehydroabietic acid and esters thereof
JPS609035B2 (en) Method for producing bicyclooctane derivatives
US3746730A (en) Process for the manufacture of polyene acids
US2695313A (en) Oxidation of nonaromatic organic compounds
JPS6024781B2 (en) Method for producing cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid
US3096346A (en) Oxidation of manoyl oxide
JPH0414091B2 (en)
US3099660A (en) Synthesis of khellin and intermediates therefor
US2993056A (en) Production of the 1-6-lactone of 6-hydroxy-8-acetoxy-octanoic acid
US3282984A (en) Racemization of optically active transchrysanthemic acid
US5473085A (en) Production of (-)dodecahydro-3a,6,6,9a-tetramethyl-naphtho[2,1-b] furan
Smith The Oxidation of Flavonols by Periodic Acid1
US2518672A (en) Tetrahydroxy etiocholanic acid and esters thereof
US3433837A (en) Method of producing adamantane-2-one
US4214099A (en) Intermediates for synthesis of precursors for prostaglandins
US4122093A (en) Process for preparing a lactone
US4021425A (en) Process for producing enone intermediates
US2748147A (en) 2, 5-dialkoxy-3, 4-dihydroxytetrahydrofurans and their hydrolysates, and methods of producing them
Boorman et al. 144. Investigations of the olefinic acids. Part IX. The addition of hydrogen bromide to unsaturated acids
US2577867A (en) Preparation of beta-methylcrotonaldehyde